Anti-Vegf Agents And The Uses Of These Agents In Eye Diseases
HARUN ÇAKMAK, MÜJDAT KARABULUT, TOLGA KOCATÜRK
- Year : 2014
- Vol : 30
- Issue : 2
- Page :
93-96
Vascular endothelial growth factor (VEGF), one of the most
important mediators of angiogenesis, is upregulated during
neovascularization. In fact, anti-VEGF agents have efficacy in the
treatment of neovascular age-related macular degeneration, diabetic
retinopathy, macular edema, neovascular glaucoma, and corneal
neovascularization. In this review, which discusses the biochemistry
of VEGF and the use of the anti-VEGF agents in eye diseases.
Cite this Article As :
Çakmak H,Karabulut M,Kocatürk T.Anti-VEGF Ajanlar ve Göz Hastalıklarındaki
Kullanım Alanları. Selcuk Med J 2014;30(2): 93-96
Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File
Download Citation: BibTeX BibTeX File
Description :
None of the authors, any product mentioned in this article,
does not have a material interest in the device or drug. Research,
not supported by any external organization.
grant full access to the primary data and, if requested by the magazine
they agree to allow the examination of data.
Anti-Vegf Agents And The Uses Of These Agents In Eye Diseases
2014,
Vol.
30
(2)
Received : 02.09.2013,
Accepted : 02.09.2013,
Published Online : 13.08.2018
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;
Review Article
View as PDF
Keywords
vascular endothelial growth factor, eye diseases, antivegf
agents
